Skip to content

Market Signals, 22 November 2026

288 venture rounds read, 63 rejected as not funding, $38.9B of capital. Lead sector Health and bio at 58%. Every figure below traces to a source you can check.

What it means for your work

What separately funded teams are converging on

These are not companies, they are the shapes multiple funded teams are building independently. A pattern that keeps appearing outlives the companies funded to build it.

PatternCompaniesShape
Multi-source research to synthesised report24distributed sources -> retrieval -> synthesis -> analyst-grade report
Regulatory obligation to evidence to gap closure19regulations -> structured requirements -> company evidence -> gap analysis -> remediation
Document intelligence to professional deliverable10documents -> extraction -> structured data -> reasoning -> professional deliverable
Codebase to autonomous change8codebase -> agent -> tested pull request -> merge
Specification to produced artifact6requirement spec -> generation -> validation -> production artifact
Unstructured information to underwriting decision5unstructured financial information -> underwriting model -> investment/credit decision

Where the capital went

SectorCapitalCompanies
Health and bio$22.5B45
Everything else$6.5B112
AI and automation$3.3B47
Industrial and robotics$2.7B33
Data and infrastructure$2.6B25
Energy and climate$960M9
Commerce and marketing$212M6
Security and identity$106M3
Fintech$106M8

The largest rounds behind it

Demis Hassabis $5.0B, Health and bio

Drug Design Lab Isomorphic $5.0B series c, Health and bio

entrepreneur $5.0B, Health and bio

Your ultimate resource for small business news, entrepreneurship, business management, franchise opportunities, growth strategies and making money. Learn how to succeed.

Alphabet-backed Isomorphic $5.0B series c, Health and bio

Linework USA $1.2B, Other

Linework USA INC. Form D filing

Kalshi $1.1B, Other

See which Kalshi markets the winning traders are stacking. Verified top earners with real names, real faces and verifiable profit — tracked live.

Plural $1.1B, Other

Mirendil $1.0B series a, AI and automation

Mirendil — a frontier lab building systems that excel at AI R&D.

Graziano Seghezzi $815M, Health and bio

Fractile $720M series c, Data and infrastructure

Fractile - Radically Accelerate Frontier Model Inference

Duetti $665M, Other

Torus $500M series c, AI and automation

Torus Launches Modular AI Infrastructure, Foundry, to Meet Surging AI Inference Demand and Secures $500M in Funding

Genesis AI $500M series a, Industrial and robotics

Physical AI Leader Agile Robots $500M series f, Industrial and robotics

Science $400M series d, Health and bio

Science Corporation is a clinical-stage medical technology company.

Get this every morning

Get this every morning

What venture capital funded in the last week, what each company actually does, and the standard that governs the area. Every figure links to the report it came from. One email a day, one click to stop.

Funding is not adoption. These patterns say where investors expect demand, not where it already exists. The frameworks that govern each sector are mapped on the compliance platform, and the courses that teach them are at store.theartofservice.com.